| P2093 | author name string | Eva Medina | |
| | Dietmar Helmut Pieper | |
| P2860 | cites work | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q21034169 |
| | Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action | Q21195823 |
| | The changing epidemiology of Staphylococcus aureus? | Q22305657 |
| | Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults | Q24187768 |
| | The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) | Q24530652 |
| | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| | Plasmid-determined AmpC-type beta-lactamases | Q24535748 |
| | The chemotherapy of tuberculosis: past, present and future | Q37076746 |
| | Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection | Q37150287 |
| | Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. | Q37328515 |
| | Mechanism of penicillin action: penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases | Q37333017 |
| | Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system | Q37333088 |
| | AmpC beta-lactamases | Q37366249 |
| | Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting | Q37394211 |
| | Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States | Q37643540 |
| | Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance | Q37667216 |
| | Short course antibiotic therapy for Gram-negative hospital-acquired pneumonia in the critically ill. | Q37702585 |
| | Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance | Q37735903 |
| | Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs | Q37874018 |
| | Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. | Q37899179 |
| | MRSA: the first half century | Q37947249 |
| | Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies | Q37996299 |
| | USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus | Q37997052 |
| | OXA-48-like carbapenemases: the phantom menace | Q38002399 |
| | The rise of carbapenem-resistant Acinetobacter baumannii | Q38034800 |
| | Clinical relevance of the ESKAPE pathogens | Q38086338 |
| | New antibiotics for bad bugs: where are we? | Q38132217 |
| | Methicillin-resistant Staphylococcus aureus: an evolving pathogen | Q38171759 |
| | Totally drug-resistant tuberculosis and adjunct therapies. | Q38210265 |
| | Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review | Q38212031 |
| | Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species | Q38471963 |
| | Mechanisms of Methicillin Resistance in Staphylococcus aureus | Q38512695 |
| | Antibiotics Clinical Development and Pipeline | Q38544966 |
| | Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus | Q38898667 |
| | Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam | Q39391281 |
| | Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran | Q39561287 |
| | Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains | Q39651444 |
| | Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases | Q39671119 |
| | Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis | Q39743333 |
| | Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates | Q39815849 |
| | Evolution of plasmid-coded resistance to broad-spectrum cephalosporins | Q39850194 |
| | The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup | Q40003526 |
| | Transferable imipenem resistance in Pseudomonas aeruginosa | Q40085630 |
| | Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus | Q40345457 |
| | Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing | Q24547449 |
| | Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae | Q24550605 |
| | Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence | Q24598936 |
| | Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic | Q24614464 |
| | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications | Q24646677 |
| | Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India | Q24647709 |
| | “Celbenin” - resistant Staphylococci | Q24675132 |
| | A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 |
| | Carbapenemases: the versatile beta-lactamases | Q24685034 |
| | Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria | Q24794555 |
| | Mechanisms of vancomycin resistance in Staphylococcus aureus | Q26829312 |
| | Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control | Q26830234 |
| | Acinetobacter infection--an emerging threat to human health | Q26861494 |
| | Tuberculosis: epidemiology and control | Q27021104 |
| | Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate | Q27618301 |
| | The tuberculosis prodrug isoniazid bound to activating peroxidases | Q27649209 |
| | Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis | Q27748759 |
| | Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis | Q28248794 |
| | Vancomycin resistance in gram-positive cocci | Q28284820 |
| | Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 |
| | Selection of resistant bacteria at very low antibiotic concentrations | Q28479239 |
| | The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis | Q29615201 |
| | Nonreplicating persistence of mycobacterium tuberculosis | Q29615312 |
| | inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis | Q29617412 |
| | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 |
| | CTX-M Enzymes: Origin and Diffusion | Q30415141 |
| | A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic | Q30425667 |
| | Drug-resistant tuberculosis: time for visionary political leadership | Q30428762 |
| | Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. | Q30580647 |
| | A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus | Q30596452 |
| | Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis | Q30840887 |
| | Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymes. | Q30887081 |
| | Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group | Q31797996 |
| | Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). | Q33229748 |
| | The history of tuberculosis | Q33256207 |
| | The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. | Q41000054 |
| | A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA" | Q41259277 |
| | Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease | Q41311704 |
| | The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America | Q41445493 |
| | Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk | Q41714469 |
| | The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. | Q41990527 |
| | Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii | Q42030240 |
| | Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. | Q42112448 |
| | Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus | Q42119436 |
| | Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin | Q42150957 |
| | High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. | Q42165253 |
| | Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria | Q42181443 |
| | Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis | Q42238872 |
| | Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase | Q42630524 |
| | NDM-1-producing Escherichia coli in Germany | Q42706276 |
| | Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs | Q42924543 |
| | Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest. | Q43579030 |
| | Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). | Q43648107 |
| | Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial | Q43659894 |
| | Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). | Q43841337 |
| | Health care-associated invasive MRSA infections, 2005-2008. | Q44110236 |
| | Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition | Q44309314 |
| | Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance | Q44315414 |
| | Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii | Q44342508 |
| | Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change | Q44381596 |
| | Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin | Q44991130 |
| | Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin | Q45199316 |
| | Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates | Q46543550 |
| | Staphylococcus aureus colonization and the risk of infection in critically ill patients | Q46643817 |
| | Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. | Q46766488 |
| | Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 |
| | Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods | Q47635060 |
| | CTX-M: changing the face of ESBLs in the UK. | Q53851440 |
| | Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. | Q54347206 |
| | World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. | Q54357571 |
| | Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. | Q54401131 |
| | Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. | Q54452583 |
| | Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). | Q54469153 |
| | Streptomycin resistance in pulmonary tuberculosis. | Q54753261 |
| | Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. | Q55067143 |
| | Chemotherapy of pulmonary tuberculosis. | Q55124959 |
| | Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. | Q33901939 |
| | Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009) | Q33933879 |
| | New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis | Q33951187 |
| | Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus | Q34073487 |
| | Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii | Q34077024 |
| | Hospital-acquired infections due to gram-negative bacteria | Q34114983 |
| | Society's failure to protect a precious resource: antibiotics | Q34176981 |
| | Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. | Q34177006 |
| | Origin and evolution of European community-acquired methicillin-resistant Staphylococcus aureus | Q34237782 |
| | New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance | Q34242777 |
| | The structure of β-lactamases | Q34246186 |
| | Tuberculosis, drug resistance, and the history of modern medicine | Q34296582 |
| | Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid | Q34297556 |
| | Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production | Q34309451 |
| | Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus | Q34343212 |
| | Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections | Q34393212 |
| | Complete sequencing of an IncHI1 plasmid encoding the carbapenemase NDM-1, the ArmA 16S RNA methylase and a resistance-nodulation-cell division/multidrug efflux pump | Q34411766 |
| | The role of nasal carriage in Staphylococcus aureus infections | Q34470454 |
| | Vancomycin: a history | Q34472263 |
| | Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance | Q34547868 |
| | The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. | Q34762753 |
| | Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 |
| | Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. | Q34973711 |
| | Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. | Q34974467 |
| | The changing epidemiology of resistance | Q34997021 |
| | Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae | Q35005872 |
| | Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes | Q35006613 |
| | Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms | Q35007624 |
| | Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality | Q35149050 |
| | Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus | Q35166213 |
| | Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification | Q35322267 |
| | ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type | Q35459274 |
| | Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing | Q35541277 |
| | Global trends in antimicrobial use in food animals | Q35590366 |
| | High prevalence of bla(NDM-1) carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical Isolates in Egypt | Q35607729 |
| | Daptomycin | Q35637066 |
| | Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosa | Q35666622 |
| | Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus | Q35669530 |
| | Carbapenemase-producing Enterobacteriaceae | Q35751615 |
| | Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis | Q35897198 |
| | Current epidemiology and growing resistance of gram-negative pathogens | Q36025192 |
| | Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections | Q36063357 |
| | Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 |
| | MRSA virulence and spread. | Q36236532 |
| | Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America | Q36382134 |
| | The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 |
| | Community-associated meticillin-resistant Staphylococcus aureus | Q36438720 |
| | The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter | Q36550851 |
| | Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 |
| | Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall | Q36565462 |
| | Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? | Q36738598 |
| | The future of antibiotics and resistance | Q36741884 |
| | Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. | Q36926337 |
| | Acinetobacter infections: a growing threat for critically ill patients | Q36950581 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 3-33 | |
| P577 | publication date | 2016-07-13 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Tackling Threats and Future Problems of Multidrug-Resistant Bacteria | |
| P478 | volume | 398 | |